Literature DB >> 19592656

Fas apoptosis inhibitory molecule enhances CD40 signaling in B cells and augments the plasma cell compartment.

Hiroaki Kaku1, Thomas L Rothstein.   

Abstract

Fas apoptosis inhibitory molecule (FAIM) was cloned as a mediator of Fas resistance that is highly evolutionarily conserved but contains no known effector motifs. In this study, we report entirely new functions of FAIM that regulate B cell signaling and differentiation. FAIM acts to specifically enhance CD40 signaling for NF-kappaB activation, IRF-4 expression, and BCL-6 down-regulation in vitro, but has no effect on its own or in conjunction with LPS or anti-Ig stimulation. In keeping with its effects on IRF-4 and BCL-6, FAIM overexpression augments the plasma cell compartment in vivo. These results indicate that FAIM is a new player on the field of B cell differentiation and acts as a force multiplier for a series of events that begins with CD40 engagement and ends with plasma cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19592656      PMCID: PMC2771648          DOI: 10.4049/jimmunol.0900056

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

Review 1.  Circuitry of nuclear factor kappaB signaling.

Authors:  Alexander Hoffmann; David Baltimore
Journal:  Immunol Rev       Date:  2006-04       Impact factor: 12.988

2.  B-1 cells are deficient in Lck: defective B cell receptor signal transduction in B-1 cells occurs in the absence of elevated Lck expression.

Authors:  Rubén Francés; Joseph R Tumang; Thomas L Rothstein
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

3.  An analysis of B cell selection mechanisms in germinal centers.

Authors:  Michael E Meyer-Hermann; Philip K Maini; Dagmar Iber
Journal:  Math Med Biol       Date:  2006-05-17       Impact factor: 1.854

4.  CD45 links the B cell receptor with cell survival and is required for the persistence of germinal centers.

Authors:  Nicholas D Huntington; Yuekang Xu; Hamsa Puthalakath; Amanda Light; Simon N Willis; Andreas Strasser; David M Tarlinton
Journal:  Nat Immunol       Date:  2005-12-25       Impact factor: 25.606

5.  Graded expression of interferon regulatory factor-4 coordinates isotype switching with plasma cell differentiation.

Authors:  Roger Sciammas; A L Shaffer; Jonathan H Schatz; Hong Zhao; Louis M Staudt; Harinder Singh
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

6.  Interferon regulatory factor 3 is involved in Toll-like receptor 4 (TLR4)- and TLR3-induced IL-12p35 gene activation.

Authors:  Stanislas Goriely; Céline Molle; Muriel Nguyen; Valentina Albarani; Najate Ouled Haddou; Rongtuan Lin; Dominique De Wit; Véronique Flamand; Fabienne Willems; Michel Goldman
Journal:  Blood       Date:  2005-10-11       Impact factor: 22.113

7.  Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination.

Authors:  Ulf Klein; Stefano Casola; Giorgio Cattoretti; Qiong Shen; Marie Lia; Tongwei Mo; Thomas Ludwig; Klaus Rajewsky; Riccardo Dalla-Favera
Journal:  Nat Immunol       Date:  2006-06-11       Impact factor: 25.606

8.  Regulation of B7.1 costimulatory molecule is mediated by the IFN regulatory factor-7 through the activation of JNK in lipopolysaccharide-stimulated human monocytic cells.

Authors:  Wilfred Lim; Katrina Gee; Sasmita Mishra; Ashok Kumar
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

9.  Tracking CD40 signaling during germinal center development.

Authors:  Katia Basso; Ulf Klein; Huifeng Niu; Gustavo A Stolovitzky; Yuhai Tu; Andrea Califano; Giorgio Cattoretti; Riccardo Dalla-Favera
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

10.  Distinct gene expression profiles in different B-cell compartments in human peripheral lymphoid organs.

Authors:  Yulei Shen; Javeed Iqbal; Li Xiao; Ryan C Lynch; Andreas Rosenwald; Louis M Staudt; Simon Sherman; Karen Dybkaer; Guimei Zhou; James D Eudy; Jan Delabie; Timothy W McKeithan; Wing C Chan
Journal:  BMC Immunol       Date:  2004-09-15       Impact factor: 3.615

View more
  8 in total

1.  A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production.

Authors:  Hiroaki Kaku; Kai Fan Cheng; Yousef Al-Abed; Thomas L Rothstein
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

2.  Fas apoptosis inhibitory molecule expression in B cells is regulated through IRF4 in a feed-forward mechanism.

Authors:  Hiroaki Kaku; Thomas L Rothstein
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

3.  Crystallization and preliminary X-ray crystallographic studies of human FAIM protein.

Authors:  Guoming Li; Linglong Qu; Geng Meng; Xiaoyun Bai; Kesheng Dai; Xiaofeng Zheng
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-07-29

4.  Expression analysis, single nucleotide polymorphisms and combined genotypes in candidate genes and their associations with growth and carcass traits in Qinchuan cattle.

Authors:  Li-jun Wang; Xiao-lin Liu; Hong-liang Wang; Hua He; Zhi-xiong Li; Ling Chen
Journal:  Mol Biol Rep       Date:  2012-11-30       Impact factor: 2.316

5.  Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species.

Authors:  Hiroaki Kaku; Alexander V Ludlow; Michael F Gutknecht; Thomas L Rothstein
Journal:  Front Mol Neurosci       Date:  2021-12-14       Impact factor: 5.639

Review 6.  FAIM-L - SIVA-1: Two Modulators of XIAP in Non-Apoptotic Caspase Function.

Authors:  Elena Coccia; Montse Solé; Joan X Comella
Journal:  Front Cell Dev Biol       Date:  2022-01-10

7.  Small Heat Shock Proteins Collaborate with FAIM to Prevent Accumulation of Misfolded Protein Aggregates.

Authors:  Hiroaki Kaku; Allison R Balaj; Thomas L Rothstein
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

8.  FAIM Opposes Aggregation of Mutant SOD1 That Typifies Some Forms of Familial Amyotrophic Lateral Sclerosis.

Authors:  Hiroaki Kaku; Alexander V Ludlow; Michael F Gutknecht; Thomas L Rothstein
Journal:  Front Neurosci       Date:  2020-02-21       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.